Found 188 matching trials
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse PHASE3 Prospective, multi-center, randomized, open label comparative Phase III stu...
Show More Location
University Clinic Ulm
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer PHASE2 This research study is studying an investigational drug as a possible treat...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) PHASE2 This research study is a Phase II clinical trial. Phase II clinical trials ...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer PHASE3 This study is a registered phase III, randomized, open-label, multicenter s...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function PHASE1 This open-label, parallel group study will evaluate the pharmacokinetics an...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer PHASE1 The purpose of this study is to determine the maximal tolerated dose (MTD) ...
Show More Location
University of Alabama
Learn More & Join Trial
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers PHASE2 This phase II trial compares the effect of usual treatment of docetaxel che...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag NA Ado-trastuzumab emtansine (T-DM1) demonstrates favorable efficacy in breast...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer PHASE1 This is an open-label, multi-center, non-randomized study of the safety and...
Show More Location
Multiple Locations
Learn More & Join Trial